Biotech Values

[jbog]

MON was able to issue aggressive new 5-year EPS guidance (doubling of EPS from FY2014 to FY2019) because of the strongly accretive effect of share buybacks.

2008 4th quarter statement:
Monsanto announced that it now expects that gross profit for the entire company will grow to $9.5 billion to $9.75 billion for 2012, or roughly two- and-a-quarter times the company's 2007 base. This estimate exceeds the company's prior gross profit estimate of $8.6 billion to $9.1 billion. The company also noted that it expects to realize a compound annual growth rate for gross profit of 18 percent to 20 percent through 2012.

Actual 2012 GP = Pennies over $7 Bil. That's over 25% off the mark for a 3 year projection.

Enough said.